Eribulin, A Drug Originally Developed In Sea Sponges Can Increase Survival In Women With Triple Negative Breast Cancer
News
According to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool, eribulin, a cancer drug originally developed from sea sponges, could add an average of five months of life ... Read more